Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check3 days agoChange DetectedAdded Study Protocol and Statistical Analysis Plan PDFs, IPD sharing policy and URL, and updated to show 106 locations.SummaryDifference100%

- Check10 days agoChange DetectedRevision: v3.4.3 was added; several study documents and IPD-sharing items were removed from the study record.SummaryDifference17%

- Check18 days agoChange DetectedCore study details, eligibility criteria, outcomes, and locations remain unchanged. The differences observed are limited to formatting/UI elements and a timestamp update.SummaryDifference0.1%

- Check25 days agoChange DetectedNo additions or deletions were described for this page in the provided input.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 on the page; no study data, results, or functionality are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision bumped from v3.4.0 to v3.4.1 with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.